This company listing is no longer active
Scandinavian ChemoTech Future Growth
Future criteria checks 2/6
Scandinavian ChemoTech is forecast to grow earnings and revenue by 25.9% and 54.5% per annum respectively.
Key information
25.9%
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 32.8% |
Revenue growth rate | 54.5% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 08 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 21 | -9 | N/A | N/A | 1 |
12/31/2025 | 13 | -12 | N/A | N/A | 1 |
12/31/2024 | 7 | -15 | N/A | N/A | 1 |
3/31/2024 | 4 | -19 | -19 | -18 | N/A |
12/31/2023 | 3 | -21 | -19 | -18 | N/A |
9/30/2023 | 3 | -22 | -20 | -20 | N/A |
6/30/2023 | 2 | -23 | -21 | -21 | N/A |
3/31/2023 | 0 | -23 | -20 | -19 | N/A |
12/31/2022 | 0 | -23 | -20 | -19 | N/A |
9/30/2022 | 0 | -22 | -23 | -20 | N/A |
6/30/2022 | 0 | -22 | -25 | -22 | N/A |
3/31/2022 | 2 | -20 | -22 | -18 | N/A |
12/31/2021 | 3 | -18 | -22 | -19 | N/A |
9/30/2021 | 3 | -15 | -15 | -13 | N/A |
6/30/2021 | 3 | -12 | -11 | -9 | N/A |
3/31/2021 | 2 | -11 | -12 | -10 | N/A |
12/31/2020 | 1 | -12 | -10 | -8 | N/A |
9/30/2020 | 2 | -14 | -16 | -12 | N/A |
6/30/2020 | 2 | -14 | -16 | -12 | N/A |
3/31/2020 | 4 | -13 | -16 | -12 | N/A |
12/31/2019 | 5 | -12 | -16 | -11 | N/A |
9/30/2019 | 5 | -10 | -10 | -6 | N/A |
6/30/2019 | 6 | -9 | -13 | -8 | N/A |
3/31/2019 | 5 | -9 | -10 | -6 | N/A |
12/31/2018 | 5 | -8 | -9 | -5 | N/A |
9/30/2018 | 4 | -6 | -12 | -9 | N/A |
6/30/2018 | 4 | -6 | -8 | -5 | N/A |
3/31/2018 | 3 | -7 | -11 | -9 | N/A |
12/31/2017 | 2 | -8 | N/A | -10 | N/A |
9/30/2017 | 2 | -10 | N/A | N/A | N/A |
6/30/2017 | 2 | -8 | N/A | -8 | N/A |
3/31/2017 | 2 | -6 | N/A | N/A | N/A |
12/31/2016 | 2 | -4 | N/A | N/A | N/A |
9/30/2016 | 1 | -2 | N/A | N/A | N/A |
6/30/2016 | 1 | -1 | N/A | 4 | N/A |
6/30/2015 | N/A | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CMOTEC BTA B is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CMOTEC BTA B is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CMOTEC BTA B is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CMOTEC BTA B's revenue (54.5% per year) is forecast to grow faster than the Swedish market (1.7% per year).
High Growth Revenue: CMOTEC BTA B's revenue (54.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CMOTEC BTA B's Return on Equity is forecast to be high in 3 years time